In contrast to PSA and other serum- or urine-based biomarkers that infer cancer risk indirectly [18,19,20,21], PROSTest captures direct gene expression signals associated with PCa through analysis of whole-blood mRNA at the molecular level. Here, KLK3 is linked to cancer.